These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26356)

  • 1. Pyridine nucleotide involvement in rat hepatic microsomal drug metabolism--III. The influence of the 1,4,5,6-tetrahydronicotinamide analogue of NADP on the NADPH kinetics of aminopyrine-N-demethylation.
    Gourlay GK; Stock BH
    Biochem Pharmacol; 1978 Mar; 27(6):979-83. PubMed ID: 26356
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of cytochrome P-450-dependent aminopyrine N-demethylase in rat brain: comparison with hepatic aminopyrine N-demethylation.
    Marietta MP; Vesell ES; Hartman RD; Weisz J; Dvorchik BH
    J Pharmacol Exp Ther; 1979 Feb; 208(2):271-9. PubMed ID: 33263
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of pyridine nucleotide cofactors in the reaction of microsomal N-demethylation under normal conditions and in tumor pathology].
    Komov VP; Firsova VI; Vennikas OR; Sinakevich NV
    Vopr Med Khim; 1985; 31(6):132-5. PubMed ID: 4090379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyridine nucleotide involvement in rat hepatic microsomal drug metabolism--IV. Inhibition of aminopyrine and ethylmorphine-N-demethylases by 2.6-dihydroxy-acetophenone.
    Gourlay GK; Stock BH
    Biochem Pharmacol; 1979 Apr; 28(8):1421-5. PubMed ID: 36098
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyridine nucleotide involvement in rat hepatic drug metabolism. The influence of NADH on the NADPH kinetics of phenobarbital pre-treated rat microsomes.
    Penglis S; Gourlay GK; Stock BH
    Aust J Exp Biol Med Sci; 1980 Feb; 58(1):49-60. PubMed ID: 6778467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridine nucleotide involvement in rat hepatic microsomal drug metabolism--II. Evidence for a co-operative interaction between NADPH and NADH.
    Gourlay GK; Stock BH
    Biochem Pharmacol; 1978 Mar; 27(6):969-78. PubMed ID: 26355
    [No Abstract]   [Full Text] [Related]  

  • 7. Microsomal enzyme activity in perfused rat liver.
    Bartosek I; Guaitani A; Garattini S; Simonazzi I
    Biochem Pharmacol; 1974 Feb; 23(3):599-605. PubMed ID: 4150812
    [No Abstract]   [Full Text] [Related]  

  • 8. NADPH-dependent lipid peroxidation and its effects on aminopyrine N-demethylation in subcellular fractions of human neonatal liver.
    Renton KW; Aranda JV; Eade NR
    Can J Physiol Pharmacol; 1976 Dec; 54(6):838-43. PubMed ID: 14776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stoichiometry of aminopyrine demethylation with and without NADH synergism.
    Jansson I; Schenkman JB
    Drug Metab Dispos; 1981; 9(5):461-5. PubMed ID: 6117446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of lipid peroxidation in carbon tetrachloride-induced loss of aminopyrine demethylase, cytochrome P-450 and glucose 6-phosphatase.
    Glende EA; Hruszkewycz AM; Recknagel RO
    Biochem Pharmacol; 1976 Oct; 25(19):2163-70. PubMed ID: 9947
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of ischemia on drug-metabolizing microsomal enzymes in rat liver.
    Ferrero ME; Orsi R; Bernelli-Zazzera A
    Exp Mol Pathol; 1978 Apr; 28(2):256-66. PubMed ID: 24548
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of riboflavin deficiency on phenobarbital and 3-methylcholanthrene induction of microsomal drug-metabolizing enzymes of the rat.
    Shargel L; Mazel P
    Biochem Pharmacol; 1973 Oct; 22(19):2365-73. PubMed ID: 4147670
    [No Abstract]   [Full Text] [Related]  

  • 13. Pyridine nucleotide involvement in rat hepatic microsomal drug metabolism--I. Factors that influence NADPH kinetic estimations during mixed function oxidase reactions.
    Gourlay GK; Stock BH
    Biochem Pharmacol; 1978 Mar; 27(6):965-8. PubMed ID: 26354
    [No Abstract]   [Full Text] [Related]  

  • 14. Pyridine nucleotide cofactor requirements of indicine N-oxide reduction by hepatic microsomal cytochrome P-450.
    Powis G; Wincentsen L
    Biochem Pharmacol; 1980 Feb; 29(3):347-51. PubMed ID: 6767485
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interaction of methylmethacrylate and acrylamide with the microsomal oxidation system of the rat liver].
    Kotlovskiĭ IuV; Grishanova AIu; Ivanov VV
    Vopr Med Khim; 1984; 30(5):44-7. PubMed ID: 6442037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of microsomal ethanol oxidation from cytochrome P-450 catalyzed drug metabolism.
    Vatsis KP; Schulman MP
    Adv Exp Med Biol; 1975; 58(00):369-82. PubMed ID: 239541
    [No Abstract]   [Full Text] [Related]  

  • 17. Caffeine demethylase activity in human and Dark Agouti rat liver microsomes. Comparison with aminopyrine N-demethylase activity.
    Agúndez JA; Luengo A; Benítez J
    Drug Metab Dispos; 1992; 20(3):343-9. PubMed ID: 1521502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct measurement of aminopyrine N-demethylase and antipyrine hydroxylase activities in a monolayer rat primary isolated hepatocyte system.
    Kotake AN
    Biochem Pharmacol; 1981 Sep; 30(17):2473-9. PubMed ID: 21043248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Effect of acetaldehyde on hepatic microsomal drug-metabolizing enzyme activities in vitro.
    Kinoshita G; Tsukada M; Shioara E; Nakanishi S
    Jpn J Pharmacol; 1974; 24(0):s:96. PubMed ID: 4151687
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of rat liver monooxygenase activities by 2-methyl-1,4-naphthoquinone (menadione).
    Floreani M; Carpenedo F
    Toxicol Appl Pharmacol; 1990 Sep; 105(2):333-9. PubMed ID: 2219123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.